Effects of Intranasal Oxytocin on Emotion Regulation in Adolescents

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

April 29, 2014

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
EmotionParent-Child Relations
Interventions
DRUG

Oxytocin

OT spray will be performed by the research pharmacy at the University Regional Hospital Pharmacy of Besançon. The placebo contained all inactive ingredients except for the neuropeptide. Placebo and OT spray containers will be prepared to look identical and will be counterbalance to be randomly assigned by the pharmacy as well. Double blinding and randomization of patients in the two groups will also be carried out by the pharmacy service. Researchers, as well as participants, will be blinded to the content of the spray. Participants will be instructed to sit and take one puff every 30 seconds, alternating nostrils. Participant will take each dose in front of the clinician to assure correct administration and tolerability.

DRUG

Placebo

The placebo contained all inactive ingredients except for the neuropeptide. Participants will be instructed to sit and take one puff every 30 seconds, alternating nostrils. Participant will take each dose in front of the clinician to assure correct administration and tolerability.

Trial Locations (1)

25000

University Regional Hospital, Besançon

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Besancon

OTHER

NCT02301715 - Effects of Intranasal Oxytocin on Emotion Regulation in Adolescents | Biotech Hunter | Biotech Hunter